Novel Cervical Plate Design Lands $550,000 Funding

A novel cervical plate and cage design by ReVivo Medical, LLC, headquartered in Albany, New York, has just received just over $550,000 in seed funding. “Our goal at ReVivo Medical is to invent and bring to market medical devices that will improve patient outcomes and reduce healthcare costs,” said Gary Mittleman, president and CEO. “Obtaining FDA market clearance for our flagship devices is our next hurdle. Although less than we were targeting to raise, this financing will enable us to kick off the early stages of a clinical trial, essential for this clearance.”

Mittleman told OTW that the funds will be used “toward initiating the early stages of our 50-patient clinical trial.”

“Anterior cervical plates and interbody cages are used in over 400,000 surgical procedures each year representing a multi-billion-dollar market,” says Darryl DiRisio, M.D., Professor of Neurosurgery and A. John Popp Chair, Spinal Surgery at Albany Medical Center. “The primary measure of success in these operations is the rapid achievement of bone fusion which thereby stabilizes the spine.”

“Our cervical plate and cage implants are designed to improve bone formation and achieve a superior rate and quality of fusion as compared to the commonly used state of the art devices in use today,” explains Eric Ledet, Ph.D., chief science officer. “Additionally, the designs of our implants incorporate unique features to make it easier for the surgeon to use.”

According to CEO Mittleman, the FDA 510(k) clearance process is underway. “We are awaiting formal approval from the FDA to proceed with our trial. We have identified two sites for the trial: the Albany Medical Center and the Cleveland Clinic. Instrument sets and devices are ready to be ordered.”